0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and Japan Tardive Dyskinesia (TD) Treatment Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-17C6770
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Global and Japan Tardive Dyskinesia TD Treatment Market Size Status and Forecast 2021 2027

Global and Japan Tardive Dyskinesia (TD) Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-17C6770
Report
September 2021
107 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Global Tardive Dyskinesia (TD) Treatment Scope and Market Size
Tardive Dyskinesia (TD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tardive Dyskinesia (TD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Valbenazine
Amantadine
Tetrabenazine
Clonazepam

Segment by Application

Hospitals
Clinics
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Teva Pharma
Biogen
Johnson & Johnson
GlaxoSmithKline
Neurocrine Biosciences
Pfizer
Novartis
Sanofi
AstraZeneca
Bayer AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Valbenazine
1.2.3 Amantadine
1.2.4 Tetrabenazine
1.2.5 Clonazepam
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia (TD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia (TD) Treatment Market Perspective (2016-2027)
2.2 Tardive Dyskinesia (TD) Treatment Growth Trends by Regions
2.2.1 Tardive Dyskinesia (TD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tardive Dyskinesia (TD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tardive Dyskinesia (TD) Treatment Industry Dynamic
2.3.1 Tardive Dyskinesia (TD) Treatment Market Trends
2.3.2 Tardive Dyskinesia (TD) Treatment Market Drivers
2.3.3 Tardive Dyskinesia (TD) Treatment Market Challenges
2.3.4 Tardive Dyskinesia (TD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia (TD) Treatment Players by Revenue
3.1.1 Global Top Tardive Dyskinesia (TD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tardive Dyskinesia (TD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tardive Dyskinesia (TD) Treatment Revenue
3.4 Global Tardive Dyskinesia (TD) Treatment Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia (TD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Revenue in 2020
3.5 Tardive Dyskinesia (TD) Treatment Key Players Head office and Area Served
3.6 Key Players Tardive Dyskinesia (TD) Treatment Product Solution and Service
3.7 Date of Enter into Tardive Dyskinesia (TD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia (TD) Treatment Breakdown Data by Type
4.1 Global Tardive Dyskinesia (TD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Type (2022-2027)
5 Tardive Dyskinesia (TD) Treatment Breakdown Data by Application
5.1 Global Tardive Dyskinesia (TD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
6.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Type
6.2.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
6.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Application
6.3.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
6.4 North America Tardive Dyskinesia (TD) Treatment Market Size by Country
6.4.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
7.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type
7.2.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
7.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application
7.3.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
7.4 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country
7.4.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type
8.2.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application
8.3.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region
8.4.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
9.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type
9.2.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application
9.3.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country
9.4.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type
10.2.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application
10.3.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country
10.4.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva Pharma
11.1.1 Teva Pharma Company Details
11.1.2 Teva Pharma Business Overview
11.1.3 Teva Pharma Tardive Dyskinesia (TD) Treatment Introduction
11.1.4 Teva Pharma Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.1.5 Teva Pharma Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Tardive Dyskinesia (TD) Treatment Introduction
11.2.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Neurocrine Biosciences
11.5.1 Neurocrine Biosciences Company Details
11.5.2 Neurocrine Biosciences Business Overview
11.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Introduction
11.5.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.5.5 Neurocrine Biosciences Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Tardive Dyskinesia (TD) Treatment Introduction
11.6.4 Pfizer Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Tardive Dyskinesia (TD) Treatment Introduction
11.7.4 Novartis Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tardive Dyskinesia (TD) Treatment Introduction
11.8.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Introduction
11.9.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Tardive Dyskinesia (TD) Treatment Introduction
11.10.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.10.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Valbenazine
    Table 3. Key Players of Amantadine
    Table 4. Key Players of Tetrabenazine
    Table 5. Key Players of Clonazepam
    Table 6. Global Tardive Dyskinesia (TD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Tardive Dyskinesia (TD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Tardive Dyskinesia (TD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions (2016-2021)
    Table 10. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions (2022-2027)
    Table 12. Tardive Dyskinesia (TD) Treatment Market Trends
    Table 13. Tardive Dyskinesia (TD) Treatment Market Drivers
    Table 14. Tardive Dyskinesia (TD) Treatment Market Challenges
    Table 15. Tardive Dyskinesia (TD) Treatment Market Restraints
    Table 16. Global Tardive Dyskinesia (TD) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Tardive Dyskinesia (TD) Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Tardive Dyskinesia (TD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment as of 2020)
    Table 19. Ranking of Global Top Tardive Dyskinesia (TD) Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Tardive Dyskinesia (TD) Treatment Product Solution and Service
    Table 23. Date of Enter into Tardive Dyskinesia (TD) Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Tardive Dyskinesia (TD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 63. Teva Pharma Company Details
    Table 64. Teva Pharma Business Overview
    Table 65. Teva Pharma Tardive Dyskinesia (TD) Treatment Product
    Table 66. Teva Pharma Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 67. Teva Pharma Recent Development
    Table 68. Biogen Company Details
    Table 69. Biogen Business Overview
    Table 70. Biogen Tardive Dyskinesia (TD) Treatment Product
    Table 71. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 72. Biogen Recent Development
    Table 73. Johnson & Johnson Company Details
    Table 74. Johnson & Johnson Business Overview
    Table 75. Johnson & Johnson Tardive Dyskinesia (TD) Treatment Product
    Table 76. Johnson & Johnson Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 77. Johnson & Johnson Recent Development
    Table 78. GlaxoSmithKline Company Details
    Table 79. GlaxoSmithKline Business Overview
    Table 80. GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Product
    Table 81. GlaxoSmithKline Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 82. GlaxoSmithKline Recent Development
    Table 83. Neurocrine Biosciences Company Details
    Table 84. Neurocrine Biosciences Business Overview
    Table 85. Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Product
    Table 86. Neurocrine Biosciences Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 87. Neurocrine Biosciences Recent Development
    Table 88. Pfizer Company Details
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Tardive Dyskinesia (TD) Treatment Product
    Table 91. Pfizer Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 92. Pfizer Recent Development
    Table 93. Novartis Company Details
    Table 94. Novartis Business Overview
    Table 95. Novartis Tardive Dyskinesia (TD) Treatment Product
    Table 96. Novartis Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 97. Novartis Recent Development
    Table 98. Sanofi Company Details
    Table 99. Sanofi Business Overview
    Table 100. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 101. Sanofi Recent Development
    Table 102. AstraZeneca Company Details
    Table 103. AstraZeneca Business Overview
    Table 104. AstraZeneca Tardive Dyskinesia (TD) Treatment Product
    Table 105. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 106. AstraZeneca Recent Development
    Table 107. Bayer AG Company Details
    Table 108. Bayer AG Business Overview
    Table 109. Bayer AG Tardive Dyskinesia (TD) Treatment Product
    Table 110. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
    Table 111. Bayer AG Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tardive Dyskinesia (TD) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Valbenazine Features
    Figure 3. Amantadine Features
    Figure 4. Tetrabenazine Features
    Figure 5. Clonazepam Features
    Figure 6. Global Tardive Dyskinesia (TD) Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Tardive Dyskinesia (TD) Treatment Report Years Considered
    Figure 11. Global Tardive Dyskinesia (TD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Tardive Dyskinesia (TD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Tardive Dyskinesia (TD) Treatment Market Share by Players in 2020
    Figure 16. Global Top Tardive Dyskinesia (TD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Revenue in 2020
    Figure 18. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
    Figure 22. North America Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
    Figure 23. North America Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
    Figure 24. United States Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Region (2016-2027)
    Figure 40. China Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Teva Pharma Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 60. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 62. GlaxoSmithKline Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 63. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 64. Pfizer Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 66. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 67. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 68. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global and China Deep Brain Stimulation System Market Insights Forecast to 2027
Global and China Deep Brain Stimulation System Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10Z6921
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report Forecast 2021 2027
China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6U7133
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Attention Deficit Hyperactivity Disorder ADHD Market Report Forecast 2021 2027
China Attention Deficit Hyperactivity Disorder (ADHD) Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21N5737
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Autism Spectrum Disorder Market Report Forecast 2021 2027
China Autism Spectrum Disorder Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-1I362
Sat Oct 02 00:00:00 UTC 2021

Add to Cart